156 related articles for article (PubMed ID: 14604996)
1. Role of insulin receptor substrates and protein kinase C-zeta in vascular permeability factor/vascular endothelial growth factor expression in pancreatic cancer cells.
Neid M; Datta K; Stephan S; Khanna I; Pal S; Shaw L; White M; Mukhopadhyay D
J Biol Chem; 2004 Feb; 279(6):3941-8. PubMed ID: 14604996
[TBL] [Abstract][Full Text] [Related]
2. Increased Sp1 phosphorylation as a mechanism of hepatocyte growth factor (HGF/SF)-induced vascular endothelial growth factor (VEGF/VPF) transcription.
Reisinger K; Kaufmann R; Gille J
J Cell Sci; 2003 Jan; 116(Pt 2):225-38. PubMed ID: 12482909
[TBL] [Abstract][Full Text] [Related]
3. Role of protein kinase Czeta in Ras-mediated transcriptional activation of vascular permeability factor/vascular endothelial growth factor expression.
Pal S; Datta K; Khosravi-Far R; Mukhopadhyay D
J Biol Chem; 2001 Jan; 276(4):2395-403. PubMed ID: 11060301
[TBL] [Abstract][Full Text] [Related]
4. Requirement of different signaling pathways mediated by insulin-like growth factor-I receptor for proliferation, invasion, and VPF/VEGF expression in a pancreatic carcinoma cell line.
Zeng H; Datta K; Neid M; Li J; Parangi S; Mukhopadhyay D
Biochem Biophys Res Commun; 2003 Feb; 302(1):46-55. PubMed ID: 12593846
[TBL] [Abstract][Full Text] [Related]
5. Multiple regulatory pathways of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in tumors.
Mukhopadhyay D; Datta K
Semin Cancer Biol; 2004 Apr; 14(2):123-30. PubMed ID: 15018896
[TBL] [Abstract][Full Text] [Related]
6. Activation of Sp1-mediated vascular permeability factor/vascular endothelial growth factor transcription requires specific interaction with protein kinase C zeta.
Pal S; Claffey KP; Cohen HT; Mukhopadhyay D
J Biol Chem; 1998 Oct; 273(41):26277-80. PubMed ID: 9756852
[TBL] [Abstract][Full Text] [Related]
7. The von Hippel-Lindau gene product inhibits vascular permeability factor/vascular endothelial growth factor expression in renal cell carcinoma by blocking protein kinase C pathways.
Pal S; Claffey KP; Dvorak HF; Mukhopadhyay D
J Biol Chem; 1997 Oct; 272(44):27509-12. PubMed ID: 9346879
[TBL] [Abstract][Full Text] [Related]
8. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS
Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702
[TBL] [Abstract][Full Text] [Related]
9. Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma.
Pal S; Datta K; Mukhopadhyay D
Cancer Res; 2001 Sep; 61(18):6952-7. PubMed ID: 11559575
[TBL] [Abstract][Full Text] [Related]
10. Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer.
Stoeltzing O; Liu W; Reinmuth N; Fan F; Parikh AA; Bucana CD; Evans DB; Semenza GL; Ellis LM
Am J Pathol; 2003 Sep; 163(3):1001-11. PubMed ID: 12937141
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase C-zeta phosphorylates insulin receptor substrate-1, -3, and -4 but not -2: isoform specific determinants of specificity in insulin signaling.
Lee S; Lynn EG; Kim JA; Quon MJ
Endocrinology; 2008 May; 149(5):2451-8. PubMed ID: 18202124
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-alpha-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation.
Gille J; Swerlick RA; Caughman SW
EMBO J; 1997 Feb; 16(4):750-9. PubMed ID: 9049304
[TBL] [Abstract][Full Text] [Related]
13. Multiple signaling pathways mediate interleukin-4-induced 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene expression in human breast cancer cells.
Gingras S; Côté S; Simard J
Mol Endocrinol; 2000 Feb; 14(2):229-40. PubMed ID: 10674396
[TBL] [Abstract][Full Text] [Related]
14. Insulin receptor substrate-2 mediated insulin-like growth factor-I receptor overexpression in pancreatic adenocarcinoma through protein kinase Cdelta.
Kwon J; Stephan S; Mukhopadhyay A; Muders MH; Dutta SK; Lau JS; Mukhopadhyay D
Cancer Res; 2009 Feb; 69(4):1350-7. PubMed ID: 19190347
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis of the synergistic antiangiogenic activity of bevacizumab and mithramycin A.
Jia Z; Zhang J; Wei D; Wang L; Yuan P; Le X; Li Q; Yao J; Xie K
Cancer Res; 2007 May; 67(10):4878-85. PubMed ID: 17510417
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase C-zeta phosphorylates insulin receptor substrate-1 and impairs its ability to activate phosphatidylinositol 3-kinase in response to insulin.
Ravichandran LV; Esposito DL; Chen J; Quon MJ
J Biol Chem; 2001 Feb; 276(5):3543-9. PubMed ID: 11063744
[TBL] [Abstract][Full Text] [Related]
17. Regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF-A) expression in podocytes.
Datta K; Li J; Karumanchi SA; Wang E; Rondeau E; Mukhopadhyay D
Kidney Int; 2004 Oct; 66(4):1471-8. PubMed ID: 15458440
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
[TBL] [Abstract][Full Text] [Related]
19. Enhanced expression of the insulin receptor substrate-2 docking protein in human pancreatic cancer.
Kornmann M; Maruyama H; Bergmann U; Tangvoranuntakul P; Beger HG; White MF; Korc M
Cancer Res; 1998 Oct; 58(19):4250-4. PubMed ID: 9766646
[TBL] [Abstract][Full Text] [Related]
20. Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium.
Mukhopadhyay D; Nagy JA; Manseau EJ; Dvorak HF
Cancer Res; 1998 Mar; 58(6):1278-84. PubMed ID: 9515816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
